Vor Biopharma share price logo

Vor Biopharma

NASDAQ: VOR

Small Cap

$21.87

+0.47

(+2.20%)

as on

Vor Biopharma Stock Performance

as on September 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $21.44
    $22.16
    downward going graph

    1.97%

    Downside

    1.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.50
    $49.95
    downward going graph

    70.28%

    Downside

    128.40%

    Upside

    downward going graph

Vor Biopharma share price movements today

Previous Close
$21.40
Open
$21.80
Volume
1.6M
Market Cap
$1.2B
Day's Low - High
$21.44 - $22.16
52 Week Low - High
$6.50 - $49.95

Vor Biopharma Historical Returns

1 Month Return
-8.39 %
3 Month Return
+ 47.69 %
1 Year Return
-21.44 %
3 Year Return
-50.92 %
5 Year Return
-92.51 %

Vor Biopharma Stock Fundamentals & Key Indicators

Check Vor Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-325.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

-6.94

PEG Ratio

0.0000631767557067648

EBITDA

642.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-91.63%

Vor Biopharma Stock Valuation

Track how Vor Biopharma P/E has moved over time to understand its valuation trends.

Vor Biopharma in the last 5 years

  • Overview

  • Trends

Lowest (-6.27x)

December 31, 2021

Industry (-6.94x)

December 31, 2025

Today (-0.19x)

December 31, 2025

Highest (-0.19x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.19x

Vor Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vor Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$1.2B-92.51%-0.070.00%0.00%
Neutral$61.5B-64.51%-19.3-12.57%0.00%
StrongBuy$130.1B174.21%29.8186.04%0.00%
Buy$80.8B21.32%18.4884.86%0.47%

Stock Returns calculator for Vor Biopharma Stock including INR - Dollar returns

The Vor Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vor Biopharma investment value today

Current value as on today

₹87,107

Returns

-₹12,893

(-12.89%)

Returns from Vor Biopharma Stock

-₹19,714 (-19.71%)

Dollar Impact

₹6,821 (+6.82%)

Analyst Recommendation on Vor Biopharma Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Vor Biopharma. Average target price of $39

Vor Biopharma Share Price Target

Get share price movements and forecasts by analysts on Vor Biopharma.

What analysts predicted

43.92%UPSIDE

Target Price

$39

Current Price

$21.87

Analyzed by

5 Analysts

Target

$39.00

Vor Biopharma target price $39, a slight upside of 43.92% compared to current price of $21.87. According to 5 analysts rating.

Indian Investors' Interest in Vor Biopharma Stock

Search interest for Vor Biopharma Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-41% versus previous 30 day period

Vor Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
0
-
-
-
-
0
-
Operating Income
-32
-29
-28
-31
-33
-274
-28
-35
-35
-47
EBITDA
-29
-26
-26
-29
-31
-241
-812
1,722
-219
-47
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
2
0
0
0
-
Income Before Tax
-30
-27
-27
-30
-32
-1,573
-812
1,722
-219
-62
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-30
-27
-27
-30
-32
-1,573
-812
1,722
-219
-62
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vor Biopharma Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-8
-3
-
-
Operating Income
-2
-10
-43
-69
-93
-126
-121
-371
EBITDA
-2
-10
-42
-67
-83
-114
-113
-693
Interest Expense
1
0
-
-
-
-
-
-
Depreciation
0
0
0
1
8
3
3
2
Income Before Tax
-4
-10
-43
-68
-92
-117
-116
-695
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-4
-10
-43
-68
-92
-117
-116
-695
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vor Biopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-30
-27
-27
-30
-32
-1,573
-812
1,722
-219
-62
Operating Cash Flow
-30
-21
-23
-24
-31
-35
-53
-22
-38
-25
Investing Cash Flow
43
52
0
0
0
0
0
-48
-263
-36
Financing Cash Flow
0
0
0
53
0
175
21
307
74
0
Change in Cash
13
31
-23
29
-31
140
-32
236
-226
-62

Vor Biopharma Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-10
-43
-68
-92
-117
-116
-695
Operating Cash Flow
-2
-9
-36
-69
-85
-100
-99
-142
Investing Cash Flow
-
0
-4
-91
-94
71
96
-48
Financing Cash Flow
2
17
82
232
117
2
53
503
Change in Cash
0
7
42
72
-62
-26
50
312

Mutual Funds that own Vor Biopharma Stock

Check out the Mutual Funds with significant holdings in Vor Biopharma.

Funds
Holdings
Shares Held
Fidelity Select Portfolios
2.596459%
1536125
VANGUARD INDEX FUNDS
2.364046%
1398624
Fidelity Concord Street Trust
0.276429%
163542
BlackRock Funds
0.194512%
115078
TIAA-CREF Funds
0.087063%
51509

Global Institutional Holdings in Vor Biopharma

Funds
Holdings
Peter Kolchinsky
4.06%
Vanguard
4.05%
SPDR
3.34%
iShares
2.95%
Michael Rockefeller
0.64%

Insights on Vor Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, VOR stock has moved up by 47.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 53.7% return, outperforming this stock by 104.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 531.7%

About Vor Biopharma

Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases. Established in 2015, the company's headquarters are located in Cambridge, Massachusetts.
OrganisationVor Biopharma
Headquarters500 Boylston Street, Boston, MA, 02116, US
IndustryBiotechnology
CEOJean-Paul Kress
E-voting on sharesClick here to vote

Key Management of Vor Biopharma

Name

Title

Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.

Scientific Founder & Chairman of Scientific Advisory Board

Ms. Adi Osovsky

General Counsel

Mr. Dallan Murray

Chief Commercial Officer

Dr. Navid Z. Khan Ph.D.

Chief Medical Affairs Officer

Dr. Jeremy Sokolove M.D.

Chief Medical Officer

Dr. Jean-Paul Kress M.D.

Chairman, President & CEO

Mr. Sandesh Mahatme L.L.M.

Chief Business Officer & CFO

Dr. Robert Ang M.B.A., M.D., MBBS

Strategic Advisor

Ms. Carol Lincoln CCP

Head of Human Resources

FAQs

What is Vor Biopharma share price today?

Vor Biopharma share price today is $21.87 as on at the close of the market. Vor Biopharma share today touched a day high of $22.16 and a low of $21.44.

What is the 52 week high and 52 week low for Vor Biopharma share?

Vor Biopharma share touched a 52 week high of $49.95 on and a 52 week low of $6.50 on . Vor Biopharma stock price today i.e. is closed at $21.87,which is 56.22% down from its 52 week high and 236.46% up from its 52 week low.

What is Vor Biopharma's market capitalisation today?

Vor Biopharma market capitalisation is $0.00T as on .

How to invest in Vor Biopharma Stock (VOR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vor Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vor Biopharma Shares that will get you 0.0686 shares as per Vor Biopharma share price of $21.87 per share as on September 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Vor Biopharma Stock (VOR) from India?

Indian investors can start investing in Vor Biopharma (VOR) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in Vor Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Vor Biopharma share’s latest price of $21.87 as on September 22, 2026 at 1:29 am IST, you will get 0.4572 shares of Vor Biopharma. Learn more about fractional shares .

What are the returns that Vor Biopharma has given to Indian investors in the last 5 years?

Vor Biopharma stock has given -92.51% share price returns and 30.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?